ABELES JOHN H Insider Trading
Get the latest insider transactions of ABELES JOHN H. ABELES JOHN H is in Medite Cancer Diagnostics, Inc. ($MDIT) and Director in ORYX TECHNOLOGY CORP ($ORYX) and Director in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in Neurotrope, Inc. ($NTRP). Discover the current value of ABELES JOHN H shares.
Address: 2365 NW 41ST STREET BOCA RATON 33431FL
ABELES JOHN H is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| ORYX | ORYX TECHNOLOGY CORP | Director | 2,458 | 49.16 |
| DUSA | DUSA PHARMACEUTICALS INC | Director | 77,000 | 1,534,610.00 |
| NTRP | Neurotrope, Inc. | 10% Owner | 0 | 0.00 |
| MDIT | Medite Cancer Diagnostics, Inc. | 1,300,185 | 585,083.25 |
Insider Trading Transactions of ABELES JOHN H
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Oct 23 2018 | MDIT | Medite Cancer Diagnostics ... | ABELES JOHN H | Buy | 0.00 | 40,000 | 0 | 1,300,185 | |
| Oct 23 2018 | MDIT | Medite Cancer Diagnostics ... | ABELES JOHN H | Buy | 0.08 | 266,667 | 20,000 | 1,566,852 | |
| Jul 10 2018 | MDIT | Medite Cancer Diagnostics ... | ABELES JOHN H | Buy | 0.08 | 400,000 | 30,000 | 2,608,381 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.00 | 2,083 | 0 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.80 | 208,334 | 166,667 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.80 | 208,334 | 166,667 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.25 | 208,334 | 260,418 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.00 | 208,334 | 208,334 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.50 | 208,334 | 312,501 | 208,334 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.00 | 1,667 | 0 | 166,667 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.80 | 166,667 | 133,334 | 166,667 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 0.80 | 166,667 | 133,334 | 166,667 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.25 | 166,667 | 208,334 | 166,667 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.00 | 166,667 | 166,667 | 166,667 |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | 1.50 | 166,667 | 250,001 | 166,667 |
| Jul 01 2010 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 2.15 | 10,000 | 21,500 | 10,000 |
| Dec 18 2009 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 1.26 | 20,000 | 25,120 | 57,000 |
| Dec 18 2009 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 1.30 | 20,000 | 25,960 | 77,000 |
| Jul 01 2009 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 1.10 | 10,000 | 11,000 | 10,000 |
| Mar 17 2009 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 0.00 | 7,500 | 0 | 12,500 |
| Jul 01 2008 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 2.01 | 10,000 | 20,100 | 10,000 |
| Nov 14 2007 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 2.05 | 5,000 | 10,250 | 114,500 |
| Jul 02 2007 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 3.08 | 10,000 | 30,800 | 10,000 |
| Jul 05 2006 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 5.65 | 10,000 | 56,500 | 10,000 |
| Dec 08 2005 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Buy | 1.63 | 4,000 | 6,510 | 2,458 |
| Jul 22 2005 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Buy | 1.50 | 7,278 | 10,917 | 83,220 |
| Jul 22 2005 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Option Exercise | 6.00 | 5,000 | 30,000 | 0 |
| Jul 22 2005 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Option Exercise | 5.93 | 2,278 | 13,497 | 0 |
| Jul 01 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 9.30 | 10,000 | 93,000 | 10,000 |
| Jan 20 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 2.51 | 10,000 | 25,100 | 10,000 |
| Jan 20 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Buy | 6.94 | 10,000 | 69,375 | 20,000 |
| Jan 20 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Sell | 15.00 | 10,000 | 150,030 | 10,000 |
| Jan 20 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 2.51 | 10,000 | 25,100 | 0 |
| Jan 20 2005 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 6.94 | 10,000 | 69,375 | 0 |
| Jul 01 2004 | DUSA | DUSA PHARMACEUTICALS INC | ABELES JOHN H | Director | Option Exercise | 9.50 | 10,000 | 95,000 | 10,000 |
| Jul 29 2003 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Buy | 1.00 | 20,000 | 20,000 | 20,000 |
| Jul 29 2003 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Option Exercise | 3.00 | 5,000 | 15,000 | 5,000 |
| Feb 02 2002 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Buy | 2.50 | 20,000 | 50,000 | 75,942 |
| Feb 02 2002 | ORYX | ORYX TECHNOLOGY CORP | ABELES JOHN H | Director | Option Exercise | 6.00 | 5,000 | 30,000 | 5,000 |